We are pleased to share that 3-D Matrix has been ranked 179th on the list of the 500 fastest-growing companies in the Asia-Pacific region. This ranking was published by the Financial Times and created by following specific criteria such as showing the companies that achieved the highest percentage of revenue growth between 2017 and 2020 and being independent companies based in the Asia-Pacific region.
According to the published ranking, Japan had the most companies on the list in 2022, with 168 companies, followed by India with 97 companies.
We are proud to see that 3-D Matrix is among these companies as we aim to expand our business on a global scale in the fields of surgery, regenerative medicine, and DDS (drug delivery system) using self-assembled peptide technology. We continue to invest in research and development to expand our therapeutic areas within gastroenterology to cardiac surgery and ear, nose and throat (ENT) surgeries.
You can read the full article published by Financial Times [here]